Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantation-Reference-Cited by-同舟云学术

Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantation

Published:2021-03 Issue:3 Volume:34 Page:423-435
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Pfrepper Christian¹^ORCID,Herber Adam²,Weimann Antje³,Siegemund Roland⁴,Engelmann Cornelius²⁵⁶,Aehling Niklas²,Seehofer Daniel³,Berg Thomas²,Petros Sirak¹⁴

Affiliation:

1. Division of Hemostaseology Department of Medicine I University Hospital Leipzig Leipzig Germany

2. Division of Hepatology Department of Medicine II University Hospital Leipzig Leipzig Germany

3. Department of Visceral, Vascular, Thoracic and Transplant Surgery University Hospital Leipzig Leipzig Germany

4. Medical ICU University Hospital Leipzig Leipzig Germany

5. Institute for Liver and Digestive Health University College London London UK

6. Medical Department Division of Hepatology and Gastroenterology Charite ‐ Universitätsmedizin Berlin Berlin Germany

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13804

Reference33 articles.

1. Cardiovascular disease risk in patients receiving organ transplantation: a national cohort study;Tsai H‐I;Transplant Int,2017

2. Deep vein thrombosis and pulmonary embolism after solid organ transplantation: an unresolved problem;Sáez‐Giménez B;Transplant Rev,2015

3. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation;Lentine KL;Clin J Am Soc Nephrol,2006

4. Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug‐drug interaction potential;Gertz M;Pharm Res,2013

5. Insights From Practice With Use of Direct Oral Anticoagulants in Transplantation;Alsheikh R;Progr Transplant,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring safety and efficacy of rivaroxaban after living donor liver transplantation: a retrospective study;Langenbeck's Archives of Surgery;2023-08-14

2. Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients;PLOS ONE;2023-05-16

3. Apixaban/phenprocoumon/rivaroxaban;Reactions Weekly;2023-04-29

4. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

5. Trends and Outcomes of Left Atrial Appendage Occlusion in Renal and Liver Transplant Recipients: Insights From the United States National Inpatient and Readmission Database;Current Problems in Cardiology;2023-02